Liam Ratcliffe
Director at OnKure Therapeutics, Inc. (OKUR) since March 2026
Liam Ratcliffe has filed 22 insider reports with the SEC since May 2021, as director at OnKure Therapeutics, Inc. (OKUR), director at Disc Medicine, Inc. (IRON) and director at Upstream Bio, Inc. (UPB) and at 3 more companies. Liam Ratcliffe made no open-market purchases or sales in the last 12 months. The latest filing, on August 11, 2026, reports grant or award at OnKure Therapeutics, Inc. (OKUR).
- Filings
- 22
- Companies
- 6
- Bought on market
- None
- Sold on market
- $51.4M
Companies where Liam Ratcliffe is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince March 2026 | $2.70 | Aug 11, 2026 | |||||
| Directorsince December 2022 | $75.14 | Jun 23, 2026 | |||||
| Director | $1.59 | Jun 12, 2026 | |||||
| Director | $9.19 | Jun 28, 2024 | |||||
| Director | 0 | $51.4M | $6.46 | Jun 22, 2022 | |||
| Director | $3.92 | May 28, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Aug 7, 2026OKURSEC Form 4 filed by Director Ratcliffe LiamForm 4Grant or award
- Jun 18, 2026IRONSEC Form 4 filed by Director Ratcliffe LiamForm 4Grant or award
- Jun 9, 2026UPBSEC Form 4 filed by Director Ratcliffe LiamForm 4Grant or award
- Jun 4, 2026OKURSEC Form 4 filed by Director Ratcliffe LiamForm 4Grant or award
- Mar 31, 2026OKURSEC Form 4 filed by Ratcliffe LiamForm 4Grant or award
- Mar 31, 2026OKURLiam Ratcliffe became an insiderForm 3New insider
- Jun 11, 2025IRONSEC Form 4 filed by Director Ratcliffe LiamForm 4Grant or award
- Jun 10, 2025UPBSEC Form 4 filed by Director Ratcliffe LiamForm 4Grant or award
- Oct 10, 2024UPBSEC Form 4 filed by Director Ratcliffe LiamForm 4Grant or award
- Jun 26, 2024CLYMSEC Form 4 filed by Director Ratcliffe LiamForm 4Grant or award
- Jun 12, 2024IRONSEC Form 4 filed by Director Ratcliffe LiamForm 4Grant or award
- Jun 9, 2023IRONSEC Form 4 filed by Ratcliffe LiamForm 4Grant or award
- May 18, 2023CLYMSEC Form 4 filed by Ratcliffe LiamForm 4Grant or award
- Dec 29, 2022IRONSEC Form 4 filed by Ratcliffe LiamForm 4Grant or award
- Dec 29, 2022IRONLiam Ratcliffe became an insiderForm 3New insider
- Jun 16, 2022ARVNSEC Form 4 filed by Ratcliffe LiamForm 4Grant or award
- May 19, 2022CLYMSEC Form 4 filed by Ratcliffe LiamForm 4Grant or award
- Dec 16, 2021-$23.8MARVNSEC Form 4: Ratcliffe Liam sold $23,833,381 worth of shares (355,705 units at $67.00)Form 4Open-market sale
- Nov 15, 2021-$11.5MARVNSEC Form 4: Ratcliffe Liam sold $11,527,510 worth of shares (134,310 units at $85.83)Form 4Open-market sale
- Nov 9, 2021-$16MARVNSEC Form 4: Ratcliffe Liam exercised 18,423 shares at a strike of $29.56 and sold $16,006,424 worth of shares (172,079 units at $93.02), closing all direct ownership in the companyForm 4Exercise or conversion of a derivativeOpen-market sale
- Jun 8, 2021ARVNSEC Form 4 filed by Ratcliffe LiamForm 4Grant or award
- May 27, 2021PASGSEC Form 4 filed by Ratcliffe LiamForm 4Grant or award
Compare Liam Ratcliffe with
- Liam Ratcliffe vs Braden Michael Leonard2 shared
- Liam Ratcliffe vs William Jacob Savage1 shared
- Liam Ratcliffe vs David K Loomis1 shared
- Liam Ratcliffe vs Nicholas A Saccomano1 shared
- Liam Ratcliffe vs Jason A. Leverone1 shared
- Liam Ratcliffe vs Sunil Agarwal1 shared
Other insiders at the same companies
- William Jacob SavageIRON
- David K LoomisARVN
- Ra Capital Management, L.P.CLYM
- Nicholas A SaccomanoOKUR
- Jason A. LeveroneOKUR
- Sunil AgarwalARVN
- Stephen Basil ThomasCLYM
- Michael GrayUPB
- Allison AmbroseUPB
- Everett Rand SutherlandUPB
- Aaron DeykinUPB
- Adam HoughtonUPB
- John D QuiselIRON
- Kevin BittermanIRON
- Noah BerkowitzARVN
- Atlas Venture Opportunity Fund I, L.P.IRON
Questions about Liam Ratcliffe
- What is Liam Ratcliffe's role at OnKure Therapeutics, Inc.?
- Liam Ratcliffe reports to the SEC as director at OnKure Therapeutics, Inc. (OKUR), according to the latest filing on August 11, 2026. Liam Ratcliffe has also filed as director at Disc Medicine, Inc. (IRON), director at Upstream Bio, Inc. (UPB), director at Eliem Therapeutics, Inc. (CLYM) and director at Arvinas, Inc. (ARVN).
- Has Liam Ratcliffe bought or sold stock recently?
- The most recent open-market sale was on December 16, 2021: sold 355,705 shares of Arvinas, Inc. (ARVN) for $23.8M at an average of $67.00.
- How do I get alerts when Liam Ratcliffe files?
- Follow Liam Ratcliffe on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Liam Ratcliffe (SEC CIK 0001547100). Totals count each trade once, skipping amendments whose original is on file, from May 28, 2021 on. View on SEC EDGAR · Get this as JSON